|
Jan 11
|
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
|
|
Jan 10
|
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
|
|
Dec 20
|
BBLG Announces Split as Pursuit of Breakthrough Treatment Continues
|
|
Dec 18
|
Bone Biologics Announces 1-for-8 Reverse Stock Split
|
|
Sep 26
|
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device
|